GL1X · GenesisL1 explorer

MolNFT v1 · #15694 · protein

The receptor-binding domain of human B7-2

1NCN · T lymphocyte activation antigen CD86: “The receptor-binding domain of human B7-2”. X-ray diffraction, 2 pockets (best druggability 0.39). MolNFT v1 #15694 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1NCN
Type
protein
Length
220 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
T lymphocyte activation antigen CD86
UniProt
P42081
Pockets
2 · best druggability 0.39

Structure

x-ray diffraction · 1 distinct chain · 5% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BT lymphocyte activation antigen CD86protein1105% helix, 53% strandP42081

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11240.390.7530empty
2760.300.7318empty

Interfaces

1 interface between chains.

  • A–B · 463 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 1NCN · the receptor-binding domain of human B7-2 · the same entry in another collection · chain A against A, TM-score 1.00
  • P42081 · AlphaFold monomer V2.0 prediction for T-lymphocyte activation antigen CD86 (P42081) · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.